TASER International, Inc. Reports Record Revenues for Fourth Quarter and Fiscal 2006

$19.3 Million of Revenue, $3.8 Million Operating Income, $2.3 Million Net Income and $0.04 Basic and Diluted EPS for Fourth Quarter 2006


SCOTTSDALE, Ariz., Feb. 21, 2007 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR) a market leader in advanced electronic control devices today reported financial results for the fourth quarter of 2006 and the year ended December 31, 2006.

For the fourth quarter of 2006 revenues were $19.3 million, the highest quarterly revenue in the Company's history and a 53% increase over the same quarter of the prior year. Income from operations for the fourth quarter was $3.8 million an 874% increase compared with $0.4 million in the prior year period. Net income and basic and diluted earnings per share for the fourth quarter of 2006 were $2.3 million and $0.04, respectively. Business also improved sequentially as revenues in the fourth quarter of 2006 increased by $1.0 million over the third quarter of 2006.

Revenue for 2006 was a record $67.7 million, compared to revenue of $47.7 million in 2005, an increase of 42%. Due to the previously announced shareholder litigation settlement expenses of $17.65 million recorded in the second quarter of 2006, the Company recorded a net loss from operations for 2006 of $6.9 million. The net loss and basic and diluted loss per share for 2006 were $4.1 million and $0.07, respectively. In 2006, the Company increased its total cash, cash equivalents and investments balance by $3.9 million to $47.8 million at December 31, 2006 despite making the initial payment of $7.9 million as part of the settlement of the shareholder lawsuits and repurchasing $2.2 million of its own stock. The Company expects to make the final litigation settlement payment of $8.0 million in cash late in the first quarter of 2007 pending final court approval of the settlement.

Significant events in the fourth quarter of 2006 include:


 1. Seven more product liability suits were dismissed during the quarter 
    representing a total of thirty wrongful death or injury lawsuits that 
    have been dismissed, or judgment entered in favor of the Company since 
    2004. The dismissals in the fourth quarter included the Alvarado 
    litigation which was the first in-custody death trial for TASER 
    International. This central Los Angeles jury verdict was an important 
    win for both TASER International as well as the City of Los Angeles 
    Police Department. Statistics from current customers show that 
    TASER(r) Electronic Control Devices (ECDs) significantly reduce use of 
    force claims and litigation. As such, TASER believes the jury verdict 
    in the Alvarado case is an important indication that juries are seeing 
    the life-saving benefits of law enforcement using TASER technology in 
    the dangerous situations they face every day.

 2. The Company saw continued growth of TASER deployments in France with 
    $1.6 million in orders received in fourth quarter.

 3. The National Board of Directors of the League of United Latin American 
    Citizens (LULAC) unanimously passed a motion stating that LULAC should 
    continue to work with TASER International to establish best practice 
    guidelines for the proper use of TASER systems. The Company's outreach 
    and education campaigns to key public interest groups have helped to 
    build support for our technology.

 4. The National League of Cities approved a resolution from the league's 
    public safety committee encouraging the federal government to provide 
    adequate funding to local governments for the purchase of 
    state-of-the-art non-lethal technologies such as ECDs and for the
    development and promulgation of policies governing appropriate 
    training, use, and placement of ECDs in the local use of force 
    continuum.

 5. The Company announced the new TASER Remote Area Denial (TRAD) concept 
    along with a networking solution concept, the TASERNET system, which 
    may open a whole new market space for area denial and military 
    applications as early as 2008.

"I am extremely proud of the efforts of everyone at TASER International in 2006. Through perseverance, hard work and dedication, we not only overcame the considerable challenges of 2005, but delivered 42% year over year top-line revenue growth to achieve both a record revenue year and record revenue quarter," commented Rick Smith, Chief Executive Officer of TASER International, Inc.

"In 2006, we improved our core business operations, furthered our industry leading research and development programs resulting in an additional 21 U.S. and 26 International Patents filed in 2006, and enhanced our position as a market leader in accountability for non-lethal technology with the launch of the TASER CAM(tm) system. We feel we are positioned to continue the growth of our business into 2007 building upon our core law enforcement markets with the introduction of new products such as the TASER C2 personal protector and the wireless eXtended Range Electronic Projectile or XREP system," concluded Smith.

The TASER C2 personal protector is expected to ship in the second quarter of 2007 and the XREP system is expected to transition into production later in 2007.

The Company hosts its fourth quarter 2006 earnings conference call on Wednesday, February 21, 2007 at 10:00 a.m. ET. The conference call is available via web cast and can be accessed on the "Investor Relations" page at www.TASER.com. To access the teleconference, please dial: 1-866-362-4820 or 1-617-597-5345 for international callers. The pass code is 84376303 for both numbers.

About TASER International, Inc.

TASER International, Inc. provides advanced non-lethal devices for use in the law enforcement, military, private security and personal defense markets. TASER devices use proprietary technology to safely incapacitate dangerous, combative, or high-risk subjects who pose a risk to law enforcement officers, innocent citizens or themselves. TASER technology saves lives every day, and the use of TASER devices dramatically reduces injury rates for police officers, and suspects.

The TASER International logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2931

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied, or forecasted in such forward-looking statements.

TASER International, Inc. assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) order delays; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning TASER device uses; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) the timing and outcome of the final court approval of the shareholder litigation settlement and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company's Annual Report on Form 10-K and its Form 10-Qs.

The statements made herein are independent statements of TASER International, Inc. The inclusion of any third parties does not represent an endorsement of any TASER International products or services by any such third parties.

For further information contact Marcy Rigoni, Manager of Investor Relations at Marcy@TASER.com or call 800-978-2737 ext. 2011, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., 480-905-2002.


                        TASER International, Inc.
                          Statements of Income
                               (Unaudited)

 
                                          For the Three Months Ended
                                          --------------------------
                                         Dec. 31, 2006   Dec. 31, 2005
                                         -------------   -------------

 Net Sales                                $19,287,548     $12,607,749
                                          -----------     -----------

 Cost of Products Sold:
 Direct manufacturing expense               5,437,873       3,275,149
 Indirect manufacturing expense
  (including stock-based compensation
  expense of $35,121 and $0,
  respectively)                             1,647,912       1,231,270
                                          -----------     -----------
 Total Cost of Products Sold                7,085,785       4,506,419
                                          -----------     -----------

 Gross Margin                              12,201,763       8,101,330

 Sales, general and administrative
  expenses (including stock-based
  compensation of $113,077 and $0,
  respectively)                             7,698,008       7,240,943
 Research and development expenses
  (including stock-based compensation
   of $42,307 and $0, respectively)           704,744         470,455
                                          -----------     -----------

 Income from Operations                     3,799,011         389,932

 Interest income                              599,008         375,570
 Interest expense                              (1,631)         (4,105)
 Other income (expense), net                     (253)            (36)
                                          -----------     -----------

 Income before provision for income
  taxes                                     4,396,135         761,361
 Provision for income taxes                 2,079,107         582,235
                                          -----------     -----------

 Net Income                               $ 2,317,028     $   179,126
                                          ===========     ===========

 Income per common and common equivalent
  shares
 Basic                                    $      0.04     $      0.00
 Diluted                                  $      0.04     $      0.00

 Weighted average number of common and
  common equivalent shares outstanding
 Basic                                     61,928,730      61,419,984
 Diluted                                   64,752,109      63,222,162





                        TASER International, Inc.
                          Statements of Income
                               (Unaudited)


                                             For the Year Ended
                                             ------------------
                                         Dec. 31, 2006   Dec. 31, 2005
                                         -------------   -------------


 Net Sales                                $67,717,851     $47,694,181
                                          -----------     -----------

 Cost of Products Sold:
 Direct manufacturing expense              18,296,039      12,843,816
 Indirect manufacturing expense
  (including stock-based compensation
  expense of $131,086 and $0,
  respectively)                             6,242,751       5,252,470
                                          -----------     -----------

 Total Cost of Products Sold               24,538,790      18,096,286
                                          -----------     -----------

 Gross Margin                              43,179,061      29,597,895

 Sales, general and administrative
  expenses (including stock-based
  compensation of $808,341 and $0,
  respectively)                            29,680,764      26,483,485

 Research and development expenses
  (including stock-based compensation
  of $199,418 and $0, respectively)         2,704,521       1,574,048
 Litigation settlement expenses            17,650,000              --
                                          -----------     -----------

 Income (Loss) from Operations             (6,856,224)      1,540,362

 Interest income                            1,880,407       1,229,044
 Interest expense                              (7,281)         (4,208)
 Other income (expense), net                     (481)        (59,772)
                                          -----------     -----------

 Income (loss)  before provision for
  income taxes                             (4,983,579)      2,705,426
 Provision (credit) for income taxes         (895,900)      1,648,910
                                          -----------     -----------

 Net Income (Loss)                        $(4,087,679)    $ 1,056,516
                                          ===========     ===========


 Income (loss) per common and common 
  equivalent shares
 Basic                                    $     (0.07)    $      0.02
 Diluted                                  $     (0.07)    $      0.02

 Weighted average number of common and
  common equivalent shares outstanding
 Basic                                     61,984,240      61,303,939
 Diluted                                   61,984,240      63,556,246

 


                        TASER International, Inc.
                           Balance Sheets
                            (Unaudited)

                                        Dec. 31, 2006    Dec. 31, 2005
                                        -------------    -------------
               ASSETS

 Current Assets
 Cash and cash equivalents               $ 18,773,685    $ 16,351,909
 Short-term investments                     3,557,289              --
 Accounts receivable, net                  10,068,049       5,422,027
 Inventory                                  9,257,746      10,105,336
 Prepaids and other assets                  2,161,971       2,795,576
 Insurance settlement proceeds 
  receivable                                       --         575,000
 Income tax receivable                          2,031          44,454
 Current deferred income tax asset         12,295,493       6,955,500
                                         ------------    ------------
                                                        
 Total Current Assets                      56,116,264      42,249,802
 Long-term investments                     25,477,574      27,548,120
 Property and equipment, net               20,842,632      21,061,754
 Deferred income tax asset                 15,868,719      20,040,788
 Intangible assets, net                     1,532,500       1,340,783
                                         ------------    ------------
                                                        
 Total Assets                            $119,837,689    $112,241,247
                                         ============    ============
                                                        
   LIABILITIES AND STOCKHOLDERS' EQUITY                   
                                                        
 Current Liabilities                                    
 Current portion of capital lease 
  obligations                            $     45,214    $     43,111
 Accounts payable and accrued 
  liabilities                               6,789,474       6,315,654
 Current deferred revenue                   1,037,441         561,165
 Deferred insurance settlement 
  proceeds                                    509,067         476,515
 Customer deposits                            171,492         190,256
 Litigation settlement liabilities          9,750,000              --
                                         ------------    ------------
                                                        
 Total Current Liabilities                 18,302,688       7,586,701
 Capital lease obligations, net of 
  current portion                              30,974          76,188
 Deferred revenue, net of current 
  portion                                   1,975,489         839,983
 Other liabilities                            199,999              --
                                         ------------    ------------
                                                        
 Total Liabilities                         20,509,150       8,502,872
                                         ------------    ------------
                                                        
 Commitments and Contingencies                     --              --
                                                        
 Stockholders' Equity                                   
 Common stock                                     619             619
 Additional paid-in capital                80,629,659      78,742,862
 Treasury stock                            (2,208,954)             --
 Retained earnings                         20,907,215      24,994,894
                                         ------------    ------------
                                                        
 Total Stockholders' Equity                99,328,539     103,738,375
                                         ------------    ------------
                                                        
 Total Liabilities and 
  Stockholders' Equity                   $119,837,689    $112,241,247
                                         ============    ============




                        TASER International, Inc.
             Selected Statement of Cash Flows Information
                               (Unaudited)


                                             For the Year Ended
                                       Dec. 31, 2006     Dec. 31, 2005
                                       -------------     -------------

 Net income (loss)                     $ (4,087,679)     $  1,056,516
 Depreciation and amortization            2,096,596         1,712,738
 Stock-based compensation expense         1,138,845                --
 Net cash provided by operating 
  activities                              7,481,823         1,067,704
 Net cash used by investing 
  activities                             (3,555,934)         (191,114)
 Net cash provided (used) by 
  financing activities                   (1,504,113)          718,160
 Cash and Cash Equivalents, 
  end of period                        $ 18,773,685      $ 16,351,909


            

Contact Data